CalciMedica, Inc. (CALC)
NASDAQ: CALC · Real-Time Price · USD
2.760
-0.010 (-0.36%)
Dec 20, 2024, 4:00 PM EST - Market closed
CalciMedica Employees
CalciMedica had 12 employees as of December 31, 2021.
Employees
12
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,132,333
Market Cap
37.21M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2021 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Neuronetics | 203 |
| Enzo Biochem | 136 |
| OncoCyte | 46 |
| AN2 Therapeutics | 41 |
| Envoy Medical | 34 |
| SCYNEXIS | 29 |
| Elevation Oncology | 29 |
| Aileron Therapeutics | 15 |
CALC News
- 4 weeks ago - CalciMedica to Participate in the Piper Sandler 36th Annual Healthcare Conference - PRNewsWire
- 4 weeks ago - CalciMedica Announces Presentations at Upcoming Medical Meetings - PRNewsWire
- 5 weeks ago - CalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical & Corporate Updates - PRNewsWire
- 6 weeks ago - CalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial Officer - PRNewsWire
- 7 weeks ago - CalciMedica Announces Pricing of Public Offering of Common Stock - PRNewsWire
- 7 weeks ago - CalciMedica Announces Proposed Public Offering of Common Stock - PRNewsWire
- 7 weeks ago - CalciMedica to Present Late-Breaking Positive Data, Including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting - PRNewsWire
- 7 weeks ago - CalciMedica to Host a Call to Review Full Data Set, including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) - PRNewsWire